Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023

Abstract The treatment of proliferative diabetic retinopathy (PDR) has evolved significantly since the initial use of panretinal photocoagulation as a treatment in the 1950s.Vascular HEMAVOL 2 endothelial growth factor inhibitors have provided an effective alternative without the risk of peripheral vision loss.Despite this, the risk of complication

read more